Nasdaq Firm Eyes RAIN Token for Potential $212M Treasury Shift Beyond Bitcoin, Ethereum

Nasdaq-listed Enlivex Therapeutics is raising $212 million to allocate entirely to the RAIN token for its corporate treasury, marking the first institutional focus on a prediction-market altcoin over Bitcoin or Ethereum. This move highlights growing interest in specialized blockchain sectors like on-chain forecasting. Enlivex Therapeutics, a Nasdaq-listed biotech firm, plans to use 100% of $212 [...]